Novartis | NOVN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 444.6B 59.91B 2026-06
Alcon AG USD 33.76B 3.29B 2026-06
Almirall EUR 2.76B 472.53M 2025-12
Amgen USD 195.44B 5.55B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Bayer EUR 47.56B 8.87B 2026-06
Biogen USD 31.9B 5B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Fresenius EUR 22.51B 2.45B 2026-06
Fresenius Medical Care EUR 10.55B 766.96M 2026-06
Genmab DKK 17.1B 88.06B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
GRIFOLS EUR 5.41B 181.49M 2026-06
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
J&J USD 611.36B 32.21B 2026-06
Lakefront Biotherapeutics EUR 1.73B 2.64M 2026-06
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 18.98B 27.8B 2026-06
Merck USD 317.37B 20.27B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Novo Nordisk A/S DKK 1.4T 373.76B 2026-06
Orion EUR 10.15B 316M 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Philips EUR 23.09B 615.44M 2026-06
Recordati EUR 10.44B 184.5M 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
UCB EUR 46.41B 13.94B 2025-12